Aurobindo Pharma
Key Stats
52W Range
₹ 960 - 1593
MCap
₹ 72061 Cr
Volume
32 k
Div. Yield
0.4 %
Dividend
₹ 4.5
EPS
₹ 54.2
CEPS
₹ 80.1
PE Ratio
20.1
PEG
0.3
P/CE
13.6
EV/Net Sales
2.2
EV/EBITDA
10
EV/CE
1.8
P/S
2.2
P/B
2.1
Book NAV/Share
₹ 509.4
Sales Growth
16.7 %
EBITDA Growth
59.6 %
EBIT Growth
69.6 %
PAT Growth
64.4 %
EPS Growth
64.6 %
ROA
7.6 %
ROE
11.2 %
ROCE
13.8 %
D/E
0.2
Current Ratio
2
Quick Ration
1.1
Interest Cover
16.1
EBITDA Margin
9.8 %
Pre-tax Margin
7.3 %
PAT Margin
5.3 %
Tax Rate
27.7 %
Cash Profit Margin
7.9 %
Asset Turnover
1.4
Sales/Fixed Asset
2.8
Working Capital/Sales
5.2
Receivable Days
29
Payable Days
134
Inventory Days
56
Aurobindo Pharma reports strong Q1 numbers; consolidated net profit surges 61%
Aurobindo Pharma
12 Aug
USFDA concludes inspection at Unit-II of Aurobindo Pharma’s arm in Rajasthan
Aurobindo Pharma
03 May